Charles River Laboratories International (NYSE:CRL) Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS
Charles River Laboratories International (NYSE:CRL – Get Free Report) issued its earnings results on Wednesday. The medical research company reported $2.69 EPS for the quarter, beating analysts’ consensus estimates of $2.63 by $0.06, Briefing.com reports. The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. Charles River Laboratories […]